// our company

About eTheRNA

eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases. We employ messenger RNA to unleash and boost a patient’s immune response against a tumor or infectious agent. Research shows that this approach results in long lasting clinical remission in cancer patients and protective immunity against infections.

eTheRNA was established in January 2013 as a spin-off company from the ‘Vrije Universiteit Brussel’ (VUB), following the development of its TriMix mRNA technology.

// OUR COMPANY

What We Do

01

eTheRNA’s goal is to commercialize mRNA-based immunotherapies as off-the-shelf products for the treatment of cancer and infectious diseases.

LEARN MORE
01

Immunotherapies

Immunotherapies
02

eTheRNA builds on more than 30 years of research grade mRNA manufacturing, and more than 5 years of GMP mRNA production.

LEARN MORE
02

Contract Manufacturing

Contract Manufacturing

// EtheRNA

WE'D LIKE TO HEAR FROM YOU

Galileilaan 19, 2845 Niel, Belgium

Our Address

info@etherna.be

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk